The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.

Aucoin, M; Cooley, K; Saunders, PR; Cardozo, V; Remy, D; Cramer, H; Neyre Abad, C; Hannan, N

The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.

Aucoin, M Cooley, K

Saunders, PR Cardozo, V Remy, D Cramer, H Neyre Abad, C Hannan, N

Permalink

Publisher:: Elsevier BV
Publication Type:: Journal Article
Citation:: Advances in integrative medicine, 2020, 7, (4), pp. 247-251
Issue Date:: 2020-12

Closed Access

	Filename	Description	Size
	The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans A rapid .pdf	Published version	307.43 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Aucoin, M
dc.contributor.author	Cooley, K https://orcid.org/0000-0001-7960-6504
dc.contributor.author	Saunders, PR
dc.contributor.author	Cardozo, V
dc.contributor.author	Remy, D
dc.contributor.author	Cramer, H
dc.contributor.author	Neyre Abad, C
dc.contributor.author	Hannan, N
dc.date.accessioned	2021-05-20T04:22:31Z
dc.date.available	2021-05-20T04:22:31Z
dc.date.issued	2020-12
dc.identifier.citation	Advances in integrative medicine, 2020, 7, (4), pp. 247-251
dc.identifier.issn	2212-9588
dc.identifier.issn	2212-9596
dc.identifier.uri	http://hdl.handle.net/10453/149009
dc.description.abstract	<h4>Brief overview</h4>There is currently insufficient evidence to recommend quercetin supplementation as a therapy for the treatment or prevention of COVID-19. Three human clinical trials with low risk of bias suggest that oral quercetin may have a beneficial effect on the incidence and duration of respiratory tract infections in certain populations; however, further research is needed.<h4>Verdict</h4>Current evidence on the efficacy of quercetin supplementation in the treatment and prevention of COVID-19 is insufficient for its clinical recommendation at this time. Quercetin exhibits both immunomodulatory and antimicrobial effects in preclinical studies; however, only three human clinical trials, each with a low risk of bias rating, were identified in this rapid review. One study reported a decrease in incidence of upper respiratory tract infections following a competitive athletic event. A larger community clinical trial reported a benefit in older, athletic adults only.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier BV
dc.relation.ispartof	Advances in integrative medicine
dc.relation.isbasedon	10.1016/j.aimed.2020.07.007
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1104 Complementary and Alternative Medicine, 1111 Nutrition and Dietetics, 1117 Public Health and Health Services
dc.title	The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.
dc.type	Journal Article
utslib.citation.volume	7
utslib.location.activity	Netherlands
utslib.for	1104 Complementary and Alternative Medicine
utslib.for	1111 Nutrition and Dietetics
utslib.for	1117 Public Health and Health Services
utslib.for	1104 Complementary and Alternative Medicine
utslib.for	1111 Nutrition and Dietetics
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Public Health
utslib.copyright.status	closed_access	*
dc.date.updated	2021-05-20T04:22:29Z
pubs.issue	4
pubs.publication-status	Published
pubs.volume	7
utslib.citation.issue	4

Abstract:

Brief overview

There is currently insufficient evidence to recommend quercetin supplementation as a therapy for the treatment or prevention of COVID-19. Three human clinical trials with low risk of bias suggest that oral quercetin may have a beneficial effect on the incidence and duration of respiratory tract infections in certain populations; however, further research is needed.

Verdict

Current evidence on the efficacy of quercetin supplementation in the treatment and prevention of COVID-19 is insufficient for its clinical recommendation at this time. Quercetin exhibits both immunomodulatory and antimicrobial effects in preclinical studies; however, only three human clinical trials, each with a low risk of bias rating, were identified in this rapid review. One study reported a decrease in incidence of upper respiratory tract infections following a competitive athletic event. A larger community clinical trial reported a benefit in older, athletic adults only.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/149009